Kamla Molecular Medicine Private Limited - Company Profile

It is a healthcare private limited company based in Sonepat, Haryana, India, established in 2008.
2008 Sonepat, Haryana, India Struck Off
Last Updated:
Access Report
About Kamla Molecular Medicine Private Limited

Kamla Molecular Medicine Private Limited, a struck off private limited company, was established on 20 August 2008 in Sonepat, Haryana, India. Engaging in medical & surgical equipment within the healthcare sector, it holds CIN: U33110HR2008PTC038287. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M.

Its leadership includes Surender Nath (Director), Sudha Kalra (Director). It is based at 780 Sector-15, Sonepat, Haryana, 131001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33110HR2008PTC038287

  • Registration Number

    038287

  • Incorporation Date

    20 August 2008

  • Authorized Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Company Age 17 Year, 6 Months
Company report

Kamla Molecular Medicine Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kamla Molecular Medicine Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Kamla Molecular Medicine Private Limited?
Current Directors
Name Designation Appointment Date Status
Surender Nath Director 20 Aug 2008 Current
Sudha Kalra Director 20 Aug 2008 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kamla Molecular Medicine.

Enhance accessibility to Kamla Molecular Medicine's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Kamla Molecular Medicine revenue growth over time
Kamla Molecular Medicine profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kamla Molecular Medicine?

Unlock access to Kamla Molecular Medicine's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Kamla Molecular Medicine?

Unlock and access historical data on people associated with Kamla Molecular Medicine, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kamla Molecular Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kamla Molecular Medicine's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kamla Molecular Medicine
Recent Activity within the Organization
  • Director Appointment

    Surender Nath was appointed as a Director was appointed as a Director on 20 Aug 2008 & has been associated with this company since 17 years 6 months . was recorded as a recent event.

  • Director Appointment

    The activity Sudha Kalra was appointed as a Director was appointed as a Director on 20 Aug 2008 & has been associated with this company since 17 years 6 months . was completed.

  • Company Incorporation

    Kamla Molecular Medicine Private Limited was registered on 20 Aug 2008 with Roc Delhi & aged 17 years 6 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kamla Molecular Medicine Private Limited?

The CIN of Kamla Molecular Medicine Private Limited is U33110HR2008PTC038287.

Where is Kamla Molecular Medicine Private Limited headquartered?

Kamla Molecular Medicine Private Limited is headquartered at 780 Sector-15, Sonepat, Haryana, 131001.

When was Kamla Molecular Medicine Private Limited incorporated?

Kamla Molecular Medicine Private Limited was incorporated on 20 August 2008.

Who are the current directors of Kamla Molecular Medicine Private Limited?

The current directors of Kamla Molecular Medicine Private Limited are

What is the primary industry of Kamla Molecular Medicine Private Limited?

The primary industry of Kamla Molecular Medicine Private Limited is Healthcare.

Is Kamla Molecular Medicine Private Limited a listed company?

Kamla Molecular Medicine Private Limited is unlisted.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available